Security key
67080M103
Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX)
CUSIP: 67080M103
Q1 2021 13F Holders as of 31 Mar 2021
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 41,346,108
- Total 13F value
- $1,285,407,277
- Share change
- +8,208,151
- SEC-reported price per share
- $31.09
- Number of holders
- 99
- Value change
- +$254,357,641
- Number of buys
- 74
- Number of sells
- 14
- Shares outstanding
- 103,174,603
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2021
Institutions
99
Top holders
10
NRIX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2021
Previous quarter: Q4 2020
Nurix Therapeutics, Inc. SEC filings
Nurix Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 67080M103
Recent filing periods:
Ownership snapshot
Top reported holders of NRIX - Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
TRV GP III, LLC
Disclosed value leader
TRV GP III, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2020
13F
Lead comparable stake: 5.3%
Showing 1-6 of 15 holder rows.
Quick read
TRV GP III, LLC leads the comparable SEC ownership view at 5.3%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens TRV GP III, LLC's linked filing trail.
Comparable ownership
Top 5
TRV GP III, LLC
5.3%
Column Group LLC
5.2%
Redmile Group, LLC
2.8%
WELLINGTON MANAGEMENT GROUP LLP
2.4%
Foresite Capital Management IV, LLC
2.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TRV GP III, LLC |
13F
Company
|
5.3%
|
$178,293,000
5,422,549 shares
|
— | 31 Dec 2020 |
| Column Group LLC |
13F
Company
|
5.2%
|
$177,004,000
5,383,333 shares
|
— | 31 Dec 2020 |
| Redmile Group, LLC |
13F
Company
|
2.8%
|
$93,581,000
2,846,125 shares
|
— | 31 Dec 2020 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
2.4%
|
$80,342,000
2,447,584 shares
|
— | 31 Dec 2020 |
| Foresite Capital Management IV, LLC |
13F
Company
|
2.3%
|
$77,196,000
2,347,804 shares
|
— | 31 Dec 2020 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
1.7%
|
$58,820,000
1,788,921 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
99
Shares
41,346,108
Rows available
99
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
67
Q1 2021 holders
99
Holder diff
32
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 value | Q1 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend